<DOC>
	<DOCNO>NCT02678481</DOCNO>
	<brief_summary>To compare prostate cancer ( PCa ) detection rate magnetic resonance ( MR ) -targeted biopsy transrectal ultrasound ( TRUS ) -guided biopsy patient high PSA value least one previous negative prostate biopsy . Subjects submit multiparametric MR scan prostate subsequently patient suspicious MR PCa presence randomize ( 1:1 ) two study arm .</brief_summary>
	<brief_title>MR-targeted vs. Random TRUS-guided Prostate Biopsy</brief_title>
	<detailed_description>In men previously negative prostate biopsy persistent elevate PSA value , unclear biopsy strategy offer high detection rate significant PCa . The hypothesis study MR-targeted biopsy improve detection rate significant prostate cancer compare systematic TRUS-guided prostate biopsy . Men least one previously negative TRUS-guided biopsy persistently elevate PSA value ( &gt; 4 ng/ml ) submit multiparametric MR image examination prostate . Subsequently , participant suspect region MR image randomize ( 1:1 ) two study arm . In study arm A patient submit MR-targeted in-bore prostate biopsy base multiparametric MR imaging finding . In study arm B patient submit systematic TRUS-guided prostate biopsy saturation scheme .</detailed_description>
	<criteria>men age 5080 least one negative TRUSguided prostate biopsy PSA &gt; 4 ng/ml least one suspected region detect multiparametric MR imaging sign informed consent know prostate cancer diagnosis contraindication MR image uncooperative patient</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>multiparametric magnetic resonance imaging</keyword>
	<keyword>MR-targeted prostate biopsy</keyword>
	<keyword>saturation TRUS-guided prostate biopsy</keyword>
</DOC>